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Hyaluronan-induced cyclooxygenase-2 expression promotes
thromboxane A2 production by renal cells
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Physiological Institute, University of Zu¨rich-Irchel, Zu¨rich, and Division of Nephrology, Kantonsspital, St. Gallen, Switzerland
Hyaluronan-induced cyclooxygenase-2 expression promotes may function as a mediator of proinflammatory events
thromboxane A2 production by renal cells. in the kidney. In murine models of systemic lupus erythe-
Background. Matrix degradation products such as frag- matosus, increased renal production of TXA2 has beenmented hyaluronan (HA) display important proinflammatory
demonstrated both in the MRL-Faslpr and in the NZB/Weffects on renal tubular epithelial cells (TECs) and macro-
phages (MFs). We hypothesized that HA could up-regulate strains of lupus mice [2]. Likewise, the renal TXA2 pro-
cyclooxygenase type 2 (COX-2) in these cells and that the duction is markedly elevated in the active phase of hu-
subsequent production of thromboxane A2 (TXA2) could play man systemic lupus erythematosus, and urinary levelsa role in inflammatory renal lesions.
correlate with disease severity [3].Methods. We used an in vitro approach to examine the ex-
pression of COX-1 and COX-2 and the production of TXA2 Cyclooxygenases (COXs) convert arachidonic acid
in response to fragments of HA. COX-2 mRNA, protein, and into prostaglandin G2 (PGG2), which upon conversion
the resulting TXA2 production were measured in CD44-posi- into prostaglandin H2 (PGH2), serves as the substratetive, HA-responsive cells lines of TECs and MF. COX-2
for specific prostaglandin synthases such as thromboxanemRNA was also measured in vivo in MRL-Faslpr mice and in
synthase (TXS). In general, COX-1 is the constitutivelymice with anti-glomerular basement membrane (anti-GBM)
nephritis. expressed isoform, whereas the related COX-2 isoform is
Results. In TECs and MFs, HA increased the steady-state induced upon inflammatory stimulation [4–6]. However,
COX-2 mRNA and protein levels markedly, whereas COX-1
some COX-1 up-regulation has been documented in po-mRNA levels did not change. The HA-induced response was
docytes and in the anti–Thy-1 model of renal injury [7, 8].comparable to lipopolysaccharide stimulation. In comparison
with MF, the response was much weaker in TECs. Likewise, Furthermore, COX-2 is expressed in mesangial cells in
the production of TXA2 in response to HA was markedly vitro and in the macula densa in vivo [9, 10]. The factors
increased in MF, but less in TECs. In TECs and in MF, the that control the enhanced expression of COX-2 in in-HA-stimulated TXA2 synthesis was inhibited with the COX-
flammatory renal diseases are not known.2–selective inhibitors SC58125 (12.5 mmol/L) or celecoxib (0.25
We have previously shown that fragments of hyaluro-to 5.00 mmol/L). COX-2 mRNA levels were increased in ne-
phritic mice with MRL-Faslpr lupus nephritis and in mice with nan (HA) with a molecular weight in the range of 60 to
anti-GBM disease. 600 kD have proinflammatory effects, including the up-
Conclusions. HA is a proinflammatory factor that stimulates
regulation of chemokines and adhesion molecules [11, 12].COX-2 expression and subsequent TXA2 production. Since
Binding of HA to its specific cell surface receptor CD44HA accumulates markedly in renal injury, we speculate that
this matrix molecule could therefore play a significant role in leads to a cascade of cellular activation events, which
thromboxane-mediated immune events in the kidney. involves, among others, the nuclear translocation of nu-
clear factor-kB (NF-kB) [13]. As HA accumulates mark-
edly in the tubulointerstitial space in various types of
Alterations in renal eicosanoid production play a role renal injury, we were interested in examining the link
in immune-mediated renal injury [1]. Thromboxane A2 between HA and prostaglandin production. We there-
(TXA2) is one of the arachidonic acid metabolites that fore investigated the expression of COX-2 and the subse-
quent production of TXA2 in vitro in renal tubular epi-
thelial cells (TECs) and in macrophages (MFs). WeKey words: prostaglandins, lupus nephritis, anti-GBM disease, renal
injury, inflammation, matrix molecule. found that HA markedly stimulated COX-2 and TXA2
in these cells. Since HA and COX-2 are also enhanced
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in vivo in murine lupus nephritis and antiglomerularand in revised form July 31, 2000
Accepted for publication August 3, 2000 basement membrane (anti-GBM) disease, we speculate
that COX-2 could be an important mediator that controlsÓ 2001 by the International Society of Nephrology
190
Sun et al: COX-2–mediated TXA2 synthesis by HA 191
the production of inflammatory prostanoids in immune- GT-39 (450 bp fragment). The primer sequences for
mouse COX-2 were as follows: forward primer 59-CCCrenal injury.
CCA CAG TCA AAG ACA CT-39 and reverse primer
59-CCC CAA AGA TAG CAT CTG GA-39 (771 bp
METHODS
fragment). For mouse TXS, two different forward prim-
Materials ers were used, 59-GGG CCT CTG TGT GGG TAC
TA-39 or 59-ATC AGC CAA GCC TGT GAA CT-39,Tissue culture reagents were obtained from Life Tech-
nologies (Gaithersburg, MD, USA), and chemicals were and the same reverse primer 59-CCT CTC TTC TGC
TGC TTG CT-39 (360 bp and 600 bp fragments, respec-from Sigma (St. Louis, MO, USA). HA of intermediate
molecular weight (derived from human umbilical cord) and tively). The rat housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was also amplifiedlipopolysaccharide (LPS; derived from Escherichia coli)
was obtained from Sigma (Buchs, Switzerland). The COX- to control for equal amounts of RNA, as described [18].
The cycling parameters were as follows: denaturation at2–specific inhibitors SC-58125 (kindly provided by Boeh-
ringer Ingelheim, Biberach, Germany) and SC-58635 (cele- 948C for 30 seconds, annealing at 608C for one minute,
extension at 688C for two minutes over 25 to 40 cycles,coxib; Searle, Aubonne, Switzerland), and the COX-1/-2
blocker indomethacin (Sigma, St. Louis, MO, USA) were followed by the final extension at 688C for seven minutes.
Amplification was linear between 25 and 35 cycles. Theused to inhibit the HA-stimulated prostaglandin (PG)
production [14, 15]. RT-PCR was performed with a Gene Amp PCR System
9700 thermocycler (Perkin-Elmer). RT-PCR products
Cell lines and cell culture were resolved on 1% agarose gels and stained with ethid-
ium bromide. Gels were then photographed with ultravi-The mouse monocyte-macrophage cell line RAW
264.7 and the SV40-transformed mouse cortical tubular olet light.
For Northern blot analysis, 5 to 25 mg aliquots of total(MCT) cell line were used to examine the effect of HA
on COX-2 and TXB2. These cells lines have previously RNA were size fractionated by electrophoresis on 1%
agarose-formaldehyde gels and transferred to Zeta-been shown to express CD44, to bind HA, and to respond
to HA stimulation [16, 17]. Cells were grown in Petri Probet blotting membranes (Bio-Rad, Hercules, CA,
USA). Methylene blue staining to detect the 18S anddishes in Dulbecco’s modified Eagle’s medium (DMEM)
with Glutamax-1, containing 10% fetal bovine serum 28S ribosomal RNA bands was performed to ensure
equal loading. After preincubation overnight at 658C in(FBS), 10 mmol/L HEPES, 100 U/mL penicillin, and 100
mg/mL streptomycin at 378C with 5% CO2. The medium a solution containing 1 mmol/L ethylenediaminetetra-
acetic acid (EDTA), 7% sodium dodecyl sulfate (SDS)was changed to DMEM containing 1% FBS for 18 hours
to rest the cells. Cells (5 to 10 3 106) were subsequently in 0.5 mol/L Na2HPO4 (pH 7.2), the blots were hybridized
overnight with a COX-2 cDNA fragment (kindly pro-stimulated with HA fragments (1 to 1000 mg/mL) or LPS
(100 ng/mL) for various time periods. Total RNA was vided by Dr. DeWitt, East Lansing, MI, USA) previously
labeled with 32P(dCTP). Blots were washed at 658C inthen isolated for COX-1, COX-2, and TXS mRNA anal-
ysis, and cellular extracts were prepared for COX-2 im- 40 mmol/L sodium phosphate buffer with decreasing
concentrations of SDS. Autoradiography was performedmunodetection. Supernatants were harvested for TXB2
determination. using X-OMAT AR film (Kodak, Rochester, NY, USA).
Blots were rehybridized with an 800 bp cDNA probe
RNA extraction, RT-PCR, and Northern blot analysis for the housekeeping gene b-actin.
for COX-2 mRNA
Protein extraction and Western blotting for COX-2Total RNA was extracted from RAW 264.7 and MCT
cells by using the reagent Trizolt (Life Technologies) Confluent RAW 264.7 and MCT cells were stimulated
with HA or LPS for one to eight hours. For proteinand phenol/chloroform extraction according to the man-
ufacturer’s instructions. The RNA was quantitated, ly- extraction, the cells were washed twice with ice-cold
phosphate-buffered saline (PBS) and were lyzed in 1 mLophilized, and analyzed for COX-1, COX-2, and TXS
expression by semiquantitative reverse transcription- of ice-cold extraction buffer [50 mmol/L Tris-HCl, pH
7.4, 1% NP-40, 1 mmol/L EDTA, 1 mmol/L phenylmeth-polymerase chain reaction (RT-PCR), using the Access
RT-PCR kit from Promega (Madison, WI, USA). The ylsulfonyl fluoride (PMSF) and 1 3 protease inhibitor
cocktail; Sigma]. After 30 minutes, the cells were scraped50 mL reaction mixture contained 1 mg total RNA. The
reverse transcription was performed at 488C for 45 min- off and centrifuged at 10,000 r.p.m. for 20 minutes at
48C. The supernatant was collected and protein contentutes, followed by the PCR reaction. The primer se-
quences for mouse COX-1 were as follows: forward was determined by using the Bio-Rad DC protein assay.
The protein samples were mixed with 4 3 nonreducedprimer 59-ACT GGC TCT GGG AAT TTG TG-39 and
reverse primer 59-AGA GCC GCA GGT GAT ACT sample buffer (0.38 mol/L Tris base, 8% SDS, 4 mmol/L
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Fig. 1. Constitutive cyclooxygenase-1 (COX-1)
mRNA expression in response to hyaluronan
(HA) and lipopolysaccharide (LPS). RT-PCR
analysis. (A) Time course for COX-1 and the
housekeeping gene GAPDH in response to
fixed dose of HA (100 mg/mL) and LPS (100
ng/mL) in mouse cortical tubule (MCT) cells.
(B) Constitutive COX-1 expression in response
to HA and LPS in RAW 264.7 cells.
Fig. 2. COX-2 mRNA expression in MCT
cells in response to HA and LPS. (A) Time
course (Northern blotting) for COX-2 and the
housekeeping gene b-actin in response to
fixed dose of HA (100 mg/mL). (B) Dose–
response (RT-PCR) for COX-2 and GAPDH
after two hours of stimulation with increasing
doses of HA.
EDTA, 40% glycerol, and 10 mg/mL bromophenol blue, After three washings and a second blocking step for one
hour at room temperature, the blot was incubated forpH 6.8) and heated for five minutes. Equal amounts
two hours at room temperature with a rabbit anti-goatof protein extracts were separated by using 10% SDS-
IgG antibody conjugated with alkaline phosphatase (Sig-polyacrylamide gel electrophoresis (PAGE). Proteins
ma) at 1:5000. Blots were washed three times in PBSwere transferred to pure nitrocellulose membranes (Bio-
and then twice in assay buffer. After a five-minute incu-Rad Trans-Blot). COX-2 was detected by using a chemi-
bation in CDP-Star substrate solution containing Nitro-luminescent detection system (Tropix, Bedford, MA,
Block-II (1:20), the blots were exposed to a KodakUSA). Membranes were blocked for four hours at room
X-OMAT AR film.temperature. The affinity-purified polyclonal goat anti-
TXB2 assayrat COX-2 Ab (clone M-19; Santa Cruz, Santa Cruz,
CA, USA) was diluted at 1:2000 in blocking solution The content of TXB2 in supernatants of HA-stimu-
lated MCT cells and RAW 264.7 was determined byand incubated with the membrane overnight at 48C.
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had a stronger effect on COX-2 mRNA expression. Fig-
ure 3 demonstrates the results for the RAW 264.7 cell
line. HA also increased COX-2 mRNA levels in a time-
and dose-dependent fashion. Compared with MCT cells,
the up-regulation of COX-2 mRNA in response to HA
was more pronounced in RAW 264.7 cells.
Thromboxane synthase mRNA levels are increased
by HA
We then examined whether TXS is also regulated by
HA. TXS is the enzyme that converts PGH2 into TXA2.
Figure 4 demonstrates that TXS mRNA is rapidly and
transiently induced in MCT cells. In RAW 264.7 cells,
there is constitutive expression and also a weak up-regu-
lation of TXS mRNA. Thus, it appears that HA could
be promoting TXA2 synthesis by inducing both COX-2
and TXS.
Regulation of COX-2 protein expression in MF
by HAFig. 3. COX-2 mRNA expression in RAW 264.7 cells in response to
HA and LPS. (A) Time course (Northern blotting) with HA (100 Cellular extracts were prepared from MCT and RAW
mg/mL). (B) Dose–response (RT-PCR) after two hours of stimulation
264.7 cells after stimulation with HA or LPS for analysiswith HA.
of COX-2 protein expression by Western blotting.
COX-2 protein could not be detected in unstimulated
or stimulated MCT cells, presumably because of low
a sensitive and specific enzyme-linked immunosorbent
levels of expression (data not shown). Figure 5A showsassay (ELISA; Amersham, Du¨bendorf, Switzerland). The
that COX-2 protein levels increased markedly in RAWassays were performed according to the manufacturer’s
264.7 cells after stimulation with HA or LPS. As seeninstructions. Data are indicated as pg/well.
with the mRNA level, COX-2 protein expression was
stronger with LPS than with HA. Figure 5B shows a timeAnalysis of COX-2 mRNA in murine lupus nephritis
and anti-GBM disease course demonstrating maximal expression of COX-2
after four hours and a decrease thereafter.Total RNA was extracted from the kidneys of MRL-
Faslpr mice (3 to 4 months old) and from mice with accel-
Regulation of COX-2–mediated TXA2 production inerated anti-GBM disease (at day 7 of the disease), as
MF and TEC by HAdescribed previously. After quantitation, 1 mg total RNA
was reverse transcribed and amplified by RT-PCR for We then evaluated the production of TXA2 as a mea-
COX-2 as described previously in this article. sure of distal enzymatic events after COX-2 and TXS
induction. MCT and RAW 264.7 cells were stimulated
with HA (200 mg/mL) in the presence or absence ofRESULTS
COX-2 inhibitors, and the level of the TXA2 metaboliteRegulation of COX-1 and COX-2 mRNA expression
TXB2 was assayed in the supernatants. Figure 6 demon-in MF and TEC by HA
strates that HA enhanced the production of TXB2 inFirst, we examined the effect of HA on COX-1 and
MCT cells significantly. This response could be com-
COX-2 mRNA expression in MCT and RAW 264.7 cells.
pletely inhibited with the COX-2 selective inhibitors,These cell lines are known to be HA responsive. Figure
celecoxib. Figure 7 demonstrates similar results for1 demonstrates that COX-1 mRNA levels did not change
RAW 264.7 cells. Again, the TXB2 response to HA wassignificantly in both cell lines. LPS also had no effect.
much more pronounced in this MF cell line. Figure 7On the other hand, COX-2 mRNA was significantly en-
also demonstrates that the TXB2 response could be com-hanced in MCT and RAW 264.7 cells (Figs. 2 and 3). In
pletely inhibited with the COX-2–selective inhibitorsMCT cells, the effect was seen within one hour, was
SC58125 and celecoxib, suggesting that the stimulatorymaximal after two to three hours, and was decreased
effect of HA is primarily mediated by COX-2 and notthereafter. The effect of HA was dose-dependent be-
tween 1 and 1000 mg/mL. Figure 2 also shows that LPS by COX-1.
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Fig. 4. Thromboxane synthase (TXS) mRNA
expression in response to HA (100 mg/mL).
RT-PCR analysis for TXS and GAPDH. (A)
Time course with HA in MCT. (B) Time
course with HA in RAW 264.7.
Fig. 5. Western blotting for COX-2 in RAW
264.7 cells. (A) Up-regulation by LPS (100
ng/mL) and HA (200 mg/mL) is demonstrated.
(B) Time course for HA-stimulated COX-2
protein expression.
Enhanced COX-2 mRNA in murine lupus nephritis
and anti-GBM disease
It is known that HA accumulates markedly in immune-
mediated renal injury. Thus, we also examined whether
COX-2 mRNA levels were increased in vivo. Figure
8 demonstrates that renal COX-2 mRNA levels were
enhanced in MRL-Faslpr mice at three to four months of
age when renal injury is prominent, compared with non-
nephritic MRL-11 mice. Furthermore, COX-2 mRNA
levels were also enhanced in anti-GBM mice at day 7
of disease. These data demonstrate that COX-2 is up-
regulated in immune-mediated renal injury in mice.
DISCUSSION
Our data demonstrate that the stimulation of MCT
and RAW 264.7 cells with HA resulted in a marked
increase of COX-2 mRNA and protein levels. We also
found that TXS mRNA is transiently enhanced in re-
sponse to HA and that HA also enhanced the production
of TXB2 by these cells, an effect that could be completely
blocked with COX-2–selective drugs. These findings ex-
Fig. 6. Production of TXB2 in response to HA (200 mg/mL for 16 pand the number of known proinflammatory effects byhours) in MCT cells. The up-regulation is inhibited with celecoxib
(0.25 mmol/L, 1.25 mmol/L, and 5 mmol/L). fragmented HA, suggesting that a link exists between
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Fig. 7. Production of TXB2 in response to HA (200 mg/mL for 16 hours) in RAW 264.7 cells. (A) The HA-stimulated up-regulation is inhibited
with celecoxib (CEL; 25 mmol/L), SC58125 (SC; 12.5 mmol/L), and indomethacin (INDO; 20 mmol/L). (B) The HA-stimulated up-regulation of
TXB2 is inhibited with celecoxib (0.25 mmol/L, 1.25 mmol/L, and 5 mmol/L).
Fig. 8. COX-2 mRNA expression in kidney
of mice with lupus nephritis, and in mice with
anti-GBM disease by using RT-PCR analysis.
(A) COX-2 and GAPDH expression in MRL-
11 and MRL-Faslpr. (B) COX-2 and GAPDH
expression in control and in anti-GBM ne-
phritis.
the turnover of HA (synthesis and degradation) and mokines [11, 12, 17]. Based on our data that demonstrate
prostanoid production in inflammatory tissue injury. enhanced COX-2 and subsequent TXB2 generation in
Our data are in agreement with studies in human am- response to HA, we speculate that HA could also influ-
nion cells, showing that HA fragments enhance the ex- ence the regulation of prostanoid production in vivo.
pression of COX-2 and the subsequent production of Increased production of TXA2 is a feature of several
PGE2 and PGF2a [19, 20]. Although COX-2–specific drugs renal diseases, particularly lupus nephritis [reviewed in
were not tested in these studies, it was suggested that 1]. Recently, it has been shown that COX-2 is up-regu-
the effect of HA involved primarily COX-2 and not lated in human kidneys with lupus nephritis, linking ear-
COX-1. Our results with two very selective COX-2 inhib- lier observations of increased TXA2 production with the
itors show that the HA-stimulated TXB2 production enhanced expression of this enzyme [3, 28]. HA, together
could be blocked completely, proving that COX-2 and with other proinflammatory stimuli, which are known to
not COX-1 is mediating the effects of HA. up-regulate COX-2 in various cell types including MFs
Marked interstitial accumulation of HA occurs in vari- and tubular cells, could thereby disturb the local prosta-
ous inflammatory renal diseases, including anti-GBM glandin network and influence the immunologic process
nephritis, lupus nephritis, tubulointerstitial nephritis, [29–31]. Further studies will be required to examine the
and renal allograft rejection [21–25]. Synthesis and deg- in vivo relevance of our findings.
radation of HA is mediated by specific enzymes that are
expressed in the kidney [26, 27]. As the HA receptor ACKNOWLEDGMENTS
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